JP2022539804A5 - - Google Patents

Info

Publication number
JP2022539804A5
JP2022539804A5 JP2022500582A JP2022500582A JP2022539804A5 JP 2022539804 A5 JP2022539804 A5 JP 2022539804A5 JP 2022500582 A JP2022500582 A JP 2022500582A JP 2022500582 A JP2022500582 A JP 2022500582A JP 2022539804 A5 JP2022539804 A5 JP 2022539804A5
Authority
JP
Japan
Prior art keywords
linker
compound according
compound
agonist
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022500582A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022539804A (ja
JP7904596B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/041120 external-priority patent/WO2021007277A1/en
Publication of JP2022539804A publication Critical patent/JP2022539804A/ja
Publication of JP2022539804A5 publication Critical patent/JP2022539804A5/ja
Priority to JP2026009377A priority Critical patent/JP2026090286A/ja
Application granted granted Critical
Publication of JP7904596B2 publication Critical patent/JP7904596B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022500582A 2019-07-08 2020-07-08 線維性疾患状態およびがんの治療および予防のための化合物ならびに方法 Active JP7904596B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2026009377A JP2026090286A (ja) 2019-07-08 2026-01-23 線維性疾患状態およびがんの治療および予防のための化合物ならびに方法

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962871686P 2019-07-08 2019-07-08
US62/871,686 2019-07-08
US201962872146P 2019-07-09 2019-07-09
US62/872,146 2019-07-09
PCT/US2020/041120 WO2021007277A1 (en) 2019-07-08 2020-07-08 Compounds and methods for the treatment and prevention of fibrotic disease states and cancer

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2026009377A Division JP2026090286A (ja) 2019-07-08 2026-01-23 線維性疾患状態およびがんの治療および予防のための化合物ならびに方法

Publications (3)

Publication Number Publication Date
JP2022539804A JP2022539804A (ja) 2022-09-13
JP2022539804A5 true JP2022539804A5 (cg-RX-API-DMAC7.html) 2023-07-14
JP7904596B2 JP7904596B2 (ja) 2026-08-13

Family

ID=74114231

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022500582A Active JP7904596B2 (ja) 2019-07-08 2020-07-08 線維性疾患状態およびがんの治療および予防のための化合物ならびに方法
JP2026009377A Pending JP2026090286A (ja) 2019-07-08 2026-01-23 線維性疾患状態およびがんの治療および予防のための化合物ならびに方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2026009377A Pending JP2026090286A (ja) 2019-07-08 2026-01-23 線維性疾患状態およびがんの治療および予防のための化合物ならびに方法

Country Status (7)

Country Link
US (2) US12397059B2 (cg-RX-API-DMAC7.html)
EP (1) EP3996715A4 (cg-RX-API-DMAC7.html)
JP (2) JP7904596B2 (cg-RX-API-DMAC7.html)
CN (2) CN114269346A (cg-RX-API-DMAC7.html)
AU (2) AU2020310141A1 (cg-RX-API-DMAC7.html)
CA (1) CA3145908A1 (cg-RX-API-DMAC7.html)
WO (1) WO2021007277A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4337265A4 (en) * 2021-05-14 2026-03-25 Purdue Research Foundation TARGETED FOLATE RECEPTOR CONJUGATIONS WITH BRUSH-ON ENZYME-CLEVABLE BINDERS AND METHODS OF USE IN CANCER IMAGING AND TREATMENT
CN116947658B (zh) * 2023-07-28 2025-10-28 南通华祥医药科技有限公司 一种1-氨基-2-甲基-2-丙醇的合成方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060142202A1 (en) 2000-12-08 2006-06-29 3M Innovative Properties Company Compositions and methods for targeted delivery of immune response modifiers
DE60234782D1 (de) * 2001-09-28 2010-01-28 Purdue Research Foundation Behandlungsverfahren mit liganden-immunogenkonjugaten
AU2007216247A1 (en) * 2006-02-17 2007-08-23 Pfizer Limited 3 -deazapurine derivatives as TLR7 modulators
TW200902018A (en) * 2007-03-20 2009-01-16 Dainippon Sumitomo Pharma Co Novel adenine compound
CN112587671A (zh) 2012-07-18 2021-04-02 博笛生物科技有限公司 癌症的靶向免疫治疗
EP3223860A4 (en) 2014-11-25 2018-08-01 Endocyte, Inc. Methods of treating cancer by targeting tumor-associated macrophages
CN109475558A (zh) * 2016-05-25 2019-03-15 普渡研究基金会 通过靶向骨髓衍生的抑制细胞而治疗癌症的方法
AU2021305193A1 (en) * 2020-07-08 2023-02-09 Purdue Research Foundation Compounds, compositions, and methods for the treatment of fibrotic diseases and cancer

Similar Documents

Publication Publication Date Title
US8609706B2 (en) Compounds and methods for inhibiting the interaction of BCL proteins with binding partners
JP2004517049A5 (cg-RX-API-DMAC7.html)
US20230202983A1 (en) Cannabinoid receptor mediating compounds
ES2836887T3 (es) Uso de derivados de glutarimida en el tratamiento de enfermedades eosinofílicas
JP2006523216A5 (cg-RX-API-DMAC7.html)
JP2007505931A5 (cg-RX-API-DMAC7.html)
JP2016521273A5 (cg-RX-API-DMAC7.html)
JP2019500387A5 (cg-RX-API-DMAC7.html)
JP2009504763A5 (cg-RX-API-DMAC7.html)
SI2961736T1 (en) Histone demethylase inhibitors
JP2003503481A5 (cg-RX-API-DMAC7.html)
JP2009537550A5 (cg-RX-API-DMAC7.html)
JP2004525179A5 (cg-RX-API-DMAC7.html)
JP2011500638A5 (cg-RX-API-DMAC7.html)
JP2001514167A5 (cg-RX-API-DMAC7.html)
JP2019502708A5 (cg-RX-API-DMAC7.html)
JP2006508965A5 (cg-RX-API-DMAC7.html)
JP2024510939A5 (cg-RX-API-DMAC7.html)
JP2012520321A5 (cg-RX-API-DMAC7.html)
RU2002130247A (ru) Производные оксадиазола, обладающие противоопухолевым действием
JP2023544716A5 (cg-RX-API-DMAC7.html)
JP2021534160A5 (cg-RX-API-DMAC7.html)
RU2003131970A (ru) Производные 4-(фенил-пиперидин-4-илиден-метил)-бензамида и их применение для лечения боли, тревоги или желудочно-кишечных расстройств
RU2011108485A (ru) Новые (поли)аминоалкиламиноалкиламидные, алкилмочевинные или алкилсульфонамидные производные эпиподофиллотоксина, способ их получения и их применение в терапии в качестве противораковых средств
JP2004536079A5 (cg-RX-API-DMAC7.html)